Outrage of the Month: Industry Lawsuit Threatens FDA's Regulation of Drugs
Category: POLITICS
On May 7, Amarin Pharma filed an unusual lawsuit against the Food and Drug Administration (FDA), arguing that the agency's drug regulations violate the company's First Amendment free-speech rights. If Amarin prevails in its litigation, the repercussions for patient and public health will be dire.
By Michael Carome, M.D., ContributorDirector of Public Citizen's Health Research Group., 2015-06-02